Ultrafine Particles in Airways: A Novel Marker of Inflammation and Chronic Obstructive Pulmonary Disease (COPD) Exacerbation Risk
Einat Fireman Klein(Rappaport Family Institute for Research in the Medical Sciences), Aharon Kessel(Technion – Israel Institute of Technology), Yochai Adir(Rappaport Family Institute for Research in the Medical Sciences), Elizabeth Fireman(Tel Aviv Sourasky Medical Center), Amir Krencel(Bnai Zion Medical Center), Regina Peri(Technion – Israel Institute of Technology)
Cited by 1
Related Papers
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
Clinical and laboratory parameters in predicting chronic urticaria duration: a prospective study of 139 patients
|Allergy|2004|301
Randomised crossover trial of naltrexone in uraemic pruritus
|The Lancet|1996|298
Human CD19+CD25high B regulatory cells suppress proliferation of CD4+ T cells and enhance Foxp3 and CTLA-4 expression in T-regulatory cells
|Autoimmunity Reviews|2011|293
Intravenous Immunoglobulin Therapy Affects T Regulatory Cells by Increasing Their Suppressive Function
|The Journal of Immunology|2007|229